Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells

Journal of Clinical Investigation

Volumn 97, Issue 2, 1996, Pages 309-315

  Schandené, Liliane ^a   Del Prete, GianFranco F ^b   Cogan, Elle ^a   Stordeur, Patrick ^a   Crusiaux, Alain ^a   Kennes, Bernard ^c   Romagnani, Sergio ^b   Goldman, Michel ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CHU Andre Vesale   (Belgium)

Author keywords

eosinophilia; interferon alpha; interleukin 10; interleukin 5; T lymphocyte subsets

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; MITOMYCIN C; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; HYPEREOSINOPHILIC SYNDROME; LYMPHOCYTE CLONE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0030040423     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118417     Document Type: Article

References (39)

1. Zielinski, R. M., and W. D Lawrence. 1990 Interferon-α for the hypereosinophilic syndrome. Ann. Int. Med 113:716-713
2. Murphy, P. T., D. F. Fennelly, M. Stuart, and J. R O'Donnell. 1990. Alpha-interferon in a case of hypereosinophilic syndrome. Br. J. Hematol 75:619-620.
3. Butterfield, J H , and G. J. Gleich. 1994. Interferon-α treatment of 6 patients with the idiopathic hypereosmophilic syndrome. Ann. Int. Med 121.648-653.
4. MacKie, R M 1990. Interferon-alpha for atopic dermatitis. Lancet. 335: 1282-1283.
5. Gruschwitz, M. S., K. P. Peters, A. Heese, N Stosiek, H. U. Koch, and O. P. Hornstein 1993. Effects of interferon-alpha-2b on the clinical course, inflammatory infiltrates and peripheral blood lymphocytes in patients with severe atopic eczema. Int. Arch Allergy Immunol 101:20-30.
6. Broxmeyer, H. E., L. Lu, E Platzer, C. Feit, L. Juhano, and B Y. Rubin. 1983. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J. Immunol. 131:1300-1305
7. + T cell recruitment into tissue. J. Immunol 153:1264-1270.
8. Sanderson, C. J. 1992. Interleukin-5, eosinophils, and disease Blood 79: 3101-3109.
9. Gleich, G. J., C. R. Adolphson, and K. M. Leiferman. 1993. The biology of the eosinophilic leukocyte. Annu. Rev. Med. 44:85-101.
10. Coffman, R. L., B. W Seymour, S. Hudak, J. Jackson, and D Rennik. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science (Wash DC) 245.308-310.
11. Sher, A., R L. Coffman, S. Hieny, P. Scott, and A. W. Cheever. 1990. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad. Sci USA 87:61-65.
12. Owen, W. F., M. E Rothenberg, J. Petersen, P. F. Weller, D Silberstein, A L. Sheffer, R. L. Stevens, R. J. Soberman, and K. F. Austen 1989. Interleukin-5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J. Exp Med. 170:343-348.
13. Schrezenmeier, H., S. D. Thomć, F. Tewald, B Fleischer, and A. Raghavachar. 1993. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Exp. Hematol. 21:358-365.
14. Mosmann, T. R., and R L. Coffman. 1989 Th1 and Th2 cells. Different patterns of lymphokine secretion lead to different functional properties. Ann Rev. Immunol 7:145-173.
15. Romagnani, S. 1991 Human Th1 and Th2 subsets: doubt no more Immunol. Today. 12:256-257.
16. Wierenga, E. A., B. Backx, M. Snoek, L. Koenderman, and M. L. Kapsenberg. 1993. Relative contributions of human types 1 and 2 T-helper cellderived eosinophilotropic cytokines to development of eosinophilia. Blood 82. 1471-1479.
17. Schandené, L , C. Alonso-Vega, F. Willems, C. Gérard, A Delvaux, T. Velu, R. Devos, M. Deboer, and M. Goldman. 1994 B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 152. 4368-4374
18. Finkelman, F. D., A. Svetic, I. Gresser, C. Snapper, J. Holmes, P. P. Trotta, I. M. Katona, and W. C. Gause. 1991. Regulation by interferon α of immunoglobulin isotype selection and lymphokine production in mice. J. Exp. Med 174:1179-1188.
19. Parronchi, P., M. De Carli, R. Manetti, C. Simonelli, S. Sampognaro, M.-P. Piccinni, D. Macchia, E. Maggi, G. Del Prete, and S. Romagnani. 1992 IL-4 and IFN (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones J. Immunol 149.2977-2983.
20. Demeure, C. E., C. You Wu, U. Shu, P. V. Schneider, C. Heusser, H. Yssel, and G. Delespesse. 1994. In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J. Immunol. 152:4775-4782.
21. Cogan, E., L. Schandené, A. Crusiaux, P. Cochaux, T. Velu, and M. Goldman. 1994 Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J. Med. 330:535-538
22. Del Prete, G. F , M. De Carli, C. Mastromauro, R Biagiotti, D. Macchia, P Falagiani, M Ricci, and S. Romagnani. 1991 Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production J. Clin. Invest. 88.346-350.
23. Schandené, L., A Ferster, F. Mascart-Lemone, A. Crusiaux, C. Gérard, A Marchant. M. Lybin, T. Velu, E. Sariban, and M Goldman. 1993. TH2-like cells and therapeutic effects of interferon-γ in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur. J. Immunol. 23:56-60.
24. Aman, M. J., G. Rudolf, J. Goldschmitt, W. E. Aulitzky, C. Lam, C. Huber, and C. Peschel 1993. Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood. 82:2371-2378.
25. Tilg, H , J. W Mier, W Vogel, W. E. Aulitzky, C. J. Wiedermann, E Vannier, C Huber, and C. A. Dinarello. 1993. Induction of circulating IL-1 receptor antagonist by IFN treatment. J. Immunol 150:4687-4692.
26. Moore, K. W., A O'Garra, R de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993 Interleukin-10. Annu. Rev. Immunol. 11:165-190.
27. Wirth, H P., G Zala, C. Meyenberger, R Jost, R. Ammann, and R Munch. 1993. Alpha-interferon therapy in Crohn's disease, initial clinical results. Schweiz Med Wochenschr. 123:1384-1388
28. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10 deficient mice develop chronic enterocolitis. Cell. 75 263-274.
29. Langer, J. A , and S Pestka 1988. Interferon receptors. Immunol Today 9:393-400
30. Kennedy, M. K D. S Torrance, K. S. Picha, and K. M Mohler. 1992 Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery J. Immunol 149:2496-2505.
31. The IFNB Multiple Sclerosis Study Group 1993. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 43:655-661.
32. Bohjanen, P. R., M. Okajima, and R. J. Hodes 1990. Differential regulation of interleukin 4 and interleukin 5 gene expression: a comparison of T cell gene induction by anti-CD3 antibody or by exogenous lymphokines. Proc. Natl Acad Sci. USA 87: 5283-5287.
33. Rook, A. H , M. Kubin, M. Cassin, A. C. Vonderheid, B R. Vowels. J Y. Wolfe, S. F. Wolf, A. Singh, G. Trinchieri, and S. R. Lessin 1995. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J. Immunol. 154:1491-1498.
34. + T cells. J. Exp. Med. 178:1655-1663.
35. Vowels, B. R., S. R. Lessin, M. Cassin, C. Jaworski, B. Benoit, J. T. Wolfe, and A. H. Rook. 1994 Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest. Dermatol. 103:669-673.
36. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant Th2-like bronchoalvcolar T-lymphocyte population in atopic asthma. N. Engl. J. Med 326:298-304.
37. + T cells. Immunol. Today. 12:392-395.
38. Del Prete, G. 1992. Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy. 47:450-455.
39. Prin, L., J. Plumas, V. Gruart, S. Loiseau, D. Aldebert, J. C. Ameisen, A. Vermersch, P. Fenaux, O. Bletry, and M. Capron. 1991. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome. Blood. 78:2626-2632.